Eupraxia Pharmaceuticals Inc.
EPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,369 | -$8,748 | -$6,767 | -$7,532 |
| Dep. & Amort. | $63 | $55 | $46 | $55 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $446 | $1,117 | $1,493 | $1,028 |
| Change in WC | $1,701 | -$1,476 | -$707 | $569 |
| Other Non-Cash | -$347 | $736 | -$68 | -$91 |
| Operating Cash Flow | -$4,507 | -$8,315 | -$6,003 | -$5,972 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$60 | -$166 | -$169 | -$44 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $1 |
| Investing Cash Flow | -$60 | -$166 | -$169 | -$44 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $73,891 | $0 | $0 | $31,705 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7 | $240 | $430 | $26 |
| Financing Cash Flow | $73,898 | $240 | $430 | $31,731 |
| Forex Effect | -$137 | $553 | $95 | -$1,275 |
| Net Chg. in Cash | $69,194 | -$7,689 | -$5,647 | $24,439 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,766 | $27,455 | $33,101 | $8,662 |
| End Cash | $88,959 | $19,766 | $27,455 | $33,101 |
| Free Cash Flow | -$4,567 | -$8,481 | -$6,172 | -$6,017 |